✦ LIBER ✦

Vascular Function and Circulating Progenitor Cells in Thromboangiitis Obliterans (Buerger's Disease) and Atherosclerosis Obliterans

✍ Scribed by N. Idei; K. Nishioka; J. Soga

Book ID: 116712994
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 53
Category: Article
ISSN: 1097-6809
DOI: 10.1016/j.jvs.2011.04.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term survival and amputation risk i

Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)

✍ Leslie T. Cooper; Tak Sun Tse; Michael A. Mikhail; Robert D. McBane; Anthony W. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Plasminogen activators and plasminogen a

Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease)

✍ N.A. Choudhury; M.H. Pietraszek; T. Hachiya; S. Baba; S. Sakaguchi; Y. Takada; A 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 573 KB

Different subpopulations of endothelial

Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes

✍ Christian Jung; Arnar Rafnsson; Alexey Shemyakin; Felix Böhm; John Pernow 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 347 KB

The number and function of circulating e

The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease

✍ Ming-Guo Xu; Li-Na Men; Chun-Yu Zhao; Xia Zhao; Yuan-Xiang Wang; Xiang-Chun Meng 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 222 KB

Decreased level and defective function o

Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease

✍ Jin Hyun Kim; Ji-Hye Jung; Ji Hoon Phi; Hyun-Seung Kang; Jeong Eun Kim; Jong Hee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

## Abstract Circulating endothelial progenitor cells (EPCs) play an important role in physiological and pathological neovascularization and may be involved in attenuating ischemic diseases. This study aimed to characterize circulating EPCs in moyamoya disease (MMD), one of the most common pediatric

Advanced glycation end products, carotid

Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease

✍ Hiroki Ueno; Hidenori Koyama; Shinya Fukumoto; Shinji Tanaka; Takuhito Shoji; Te 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 459 KB